Predictive biomarkers for immunotherapy response in renal cell carcinoma: why have they failed?

Current Opinion in Urology · Published 2026-07-23 · DOI 10.1097/mou.0000000000001439

Free full text

Authors (5)

Felix Lübbersmeyer, Victor M. Schuettfort, Margit Fisch, Marcin Miszczyk, Shahrokh F. Shariat

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lübbersmeyer, F., Schuettfort, V., Fisch, M., et al. (2026). Predictive biomarkers for immunotherapy response in renal cell carcinoma: why have they failed?. Current Opinion in Urology. https://doi.org/10.1097/mou.0000000000001439

Related articles

• Strategies to target PD-1/PD-L1 in the tumor microenvironment · Cellular Oncology · 2026 · Cites or is cited by this article
• Multiomics in Renal Cell Carcinoma: Current Landscape and Future Directions for Precision Medicine · Current Urology Reports · 2025 · Cites or is cited by this article
• Low-intensity extracorporeal shockwave therapy as a preventive and restorative strategy in men's health: recent advances and future directions from an Asian perspective · Current Opinion in Urology · 2026 · Same journal
• Advances in laser pulse modulations · Current Opinion in Urology · 2026 · Same journal
• Experimental and translational models in urethral stricture research · Current Opinion in Urology · 2026 · Same journal
• Utility of augmented reality in endoscopic surgery for stones: European Association of Urology endourology up-to-date review · Current Opinion in Urology · 2026 · Same journal
• Engaging in urologic advocacy · Current Opinion in Urology · 2026 · Same journal
• Novel devices for intrarenal pressure monitoring: are they the future? · Current Opinion in Urology · 2026 · Same journal
• Sarcomatoid urothelial carcinoma: advances and challenges · Current Opinion in Urology · 2026 · Same journal
• Single port transvesical robotic radical prostatectomy · Current Opinion in Urology · 2026 · Same journal